Literature DB >> 15761600

Evaluation of adherence, hemagglutination, and presence of genes codifying for virulence factors of Acinetobacter baumannii causing urinary tract infection.

Graziela Braun1, Marilda Carlos Vidotto.   

Abstract

Acinetobacter baumannii is a strictly aerobic bacterium which causes severe infections, however its pathogenic characteristics are not well defined. Thirteen A. baumannii strains isolated from urine of hospitalized and nonhospitalized patients with different ages were investigated for the presence of virulence factors. The isolates belonged to biotypes 2, 6, and 9 and were sensitive to imipenem. The majority of them showed resistance to amikacin, ceftazidime, ceftriaxone, ciprofloxacin, gentamicin, norfloxacin, and trimethoprim-sulfamethoxazole. None of A. baumannii strains presented genes codifying for 17 different virulence factors previously described in uropathogenic Escherichia coli, when tested by polymerase chain reaction (PCR). Nine isolates agglutinated human group AB erythrocytes, in presence of mannose, but none of them agglutinated group O erythrocytes. Adherence to polystyrene was observed in 7 isolates, and this result did not correlate with that obtained in hemagglutination assay. All the isolates were able to grow in iron-limiting conditions, showing that A. baumannii produces some type of siderophore. However, the genes iutA and fyuA, from iron uptake system of E. coli and Yersinia sp., respectively, were not present in the isolates, suggesting the presence of a different type of siderophore. The fimbriae of A. baumannii strains that mediates the adherence are possibly mannose-resistant, even though the mechanism of adherence to human epithelial cells still remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761600     DOI: 10.1590/s0074-02762004000800010

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  7 in total

1.  Molecular Characterization and Antibiotic Susceptibility Profile of Acinetobacter baumannii Recovered from Hospital Wastewater Effluents.

Authors:  Qaqamba Mapipa; Tennison Onoriode Digban; Nonso Emmanuel Nnolim; Nolonwabo Nontongana; Anthony Ifeanyi Okoh; Uchechukwu U Nwodo
Journal:  Curr Microbiol       Date:  2022-03-08       Impact factor: 2.188

2.  Molecular and genetic characterization of emerging carbapenemase-producing Acinetobacter baumannii strains from patients and hospital environments in Bangladesh.

Authors:  Refath Farzana; Göte Swedberg; Christian G Giske; Badrul Hasan
Journal:  Infect Prev Pract       Date:  2022-04-27

3.  Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program.

Authors:  Won Suk Choi; Su Hyun Kim; Eun Gyong Jeon; Myeung Hee Son; Young Kyung Yoon; Jung-Yeon Kim; Mi Jeong Kim; Jang Wook Sohn; Min Ja Kim; Dae Won Park
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

4.  Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii.

Authors:  Bart A Eijkelkamp; Uwe H Stroeher; Karl A Hassan; Ian T Paulsen; Melissa H Brown
Journal:  BMC Genomics       Date:  2014-11-25       Impact factor: 3.969

5.  Evaluate the frequency distribution of nonadhesive virulence factors in carbapenemase-producing Acinetobacter baumannii isolated from clinical samples in Kermanshah.

Authors:  Parviz Mohajeri; Saba Sharbati; Abbas Farahani; Zhaleh Rezaei
Journal:  J Nat Sci Biol Med       Date:  2016 Jan-Jun

6.  Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii isolates.

Authors:  Chao Liu; Yaowen Chang; Ying Xu; Yun Luo; Linrong Wu; Zhanjun Mei; Shigang Li; Rui Wang; Xu Jia
Journal:  Oncotarget       Date:  2018-04-24

Review 7.  The Role of Antibiotic Resistant A. baumannii in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy.

Authors:  Natalia Bagińska; Martyna Cieślik; Andrzej Górski; Ewa Jończyk-Matysiak
Journal:  Antibiotics (Basel)       Date:  2021-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.